Recursion Pharmaceuticals Inc vs Wheaton Precious Metals Corp — how do they compare? Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B), while Wheaton Precious Metals Corp trades at $103.33 (market cap $46.54B). The key difference: Wheaton Precious Metals Corp is far larger — about 30.4× Recursion Pharmaceuticals Inc's market cap, and Wheaton Precious Metals Corp pays a 0.75% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | WPM | |
|---|---|---|
Market Cap | $1.53B | $46.54B |
Sector | Health | Basic Materials |
52-Week High | $6.79 | $165.72 |
52-Week Low | $2.84 | $91.00 |
Enterprise Value | $946.50M | $44.39B |
Dividend Yield | — | 0.75% |
Trailing returns across standard periods
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →